Genetic Test Plan Under FDA Legal Review Leaves HHS Panel Wanting More
This article was originally published in The Gray Sheet
Executive Summary
FDA's nascent program for regulating genetic tests is pending review within the Office of the Commissioner
You may also be interested in...
HHS Begs Novel Approach To Genetic Tests Pending FDA Authority Verdict
The HHS Secretary's Advisory Committee on Genetic Testing is planning on a final legal review decision from FDA on oversight and premarket review of genetic tests in time for its August meeting
HHS Begs Novel Approach To Genetic Tests Pending FDA Authority Verdict
The HHS Secretary's Advisory Committee on Genetic Testing is planning on a final legal review decision from FDA on oversight and premarket review of genetic tests in time for its August meeting
IVD Total Product Lifecycle Pilot Under Discussion By CDRH
A CDRH pilot that would seek to improve coordination of premarket and postmarket decisions for in vitro diagnostics is still under consideration, according to center officials